Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

African American women report more hair issues and use different hair care practices than Caucasian women, and have different hair and scalp characteristics.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Rasayana therapy can enhance female reproductive health at different life stages.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Bisphosphonate therapy can cause jawbone necrosis, so dental care is crucial before and during treatment.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hair transplantation has improved to look more natural, but managing patient expectations and using precise techniques are key for the best outcomes.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.